Quick Summary
Covering the latest research from top Wall Street investment banks

CICC merger timeline and integration roadmap are clearer; JPMorgan reiterates Overweight

Institution
JPMorgan
Date
2026-05-18
Authors
Zhang, Peter
Company
China International Capital Corporation Limited
Ticker
3908.HK
Industry
Banks & Financial Services
Rating
Overweight
BullishLow confidenceThe report believes the May 18 announcement clarified the merger timeline and unveiled the integration roadmap, reducing uncertainty over deal delays. Wealth management, capital reallocation, and shareholder resource synergies are now clearer, which should help boost market confidence in post-merger ROE expansion.
AuthorsZhang, Peter
Target priceHK$24.50
Asset classesEquity
SubsidiariesDongxing、Cinda、wealth management subsidiaries、futures subsidiaries、public funds subsidiaries、international subsidiaries、private equity subsidiaries、alternatives subsidiaries
Business segmentsinstitutional business、investment banking、fixed income、equity proprietary trading、asset management、research、retail brokerage、wealth management、margin financing、international business、primary market activities、secondary market activities
Research firm divisions/subsidiariesJPMorgan(Other)

AI summary card

CICC merger timeline and integration roadmap are clearer; JPMorgan reiterates Overweight

JPMorgan believes CICC's merger is expected to close in September. Synergies in institutional business, retail wealth management, and capital allocation should support improvements in earnings, EPS, and ROE, while maintaining the HK$24.50 target price.

Rating: Overweight; current price: HK$20.30; target price: HK$24.50; target date: 2026-12-31.
3908.HKCICCmerger integrationwealth management synergycapital reallocationmargin financing expansioninternational businessOverweight
  • Management expects the merger to be completed by September, with institutional business integration 3-6 months after closing, retail brokerage integration over about one year, and coverage of 15 related subsidiaries within 2-3 years.
  • The synergy framework is more specific, with key contributions from wealth management product sales, cross-selling from investment banking to wealth management, margin financing expansion, and overseas capital injections.
  • The report expects the announcement to ease investors' concerns about delays and strengthen market confidence in the post-merger ROE expansion path.
  • Valuation uses DDM and the ROE-g/COE-g terminal value method; the Dec-26 target price is HK$24.50, implying about 20.7% upside from the current HK$20.30 share price.

Report interpretation

Overview

This report is JPMorgan's update on the merger progress of China International Capital Corporation Limited (3908.HK). The core message is that after CICC held a second board meeting and disclosed a detailed merger plan, management further clarified the merger timeline, the phased integration roadmap, and the sources of synergy. The overall view is positive: uncertainty has declined and the synergy path is more verifiable, which may drive a positive share-price reaction and keep CICC H-shares as a sector top pick.

Core views

The report sees three key investment implications from the merger. First, the timeline is clearer, with management expecting the merger to be completed in September, reducing market concerns about further delays. Second, the integration roadmap is clear: institutional business will be integrated first, followed by retail brokerage and wealth management, and then more subsidiaries over the long term. Third, the synergies are more concrete: higher wealth management product sales, cross-selling from investment banking clients into wealth management, capital reallocation, margin financing expansion, and international business capital support could all lift earnings and ROE.

Analysis framework

The report mainly uses event-driven analysis based on company announcements, management calls, and Q&A. It also combines a decomposition of business synergies, capital allocation sensitivity, and a DDM valuation framework to assess the target price. The focus is not a short-term financial statement review, but the post-merger business integration pace, the path to synergy realization, and the potential upside in valuation.

Methodology notes

  • Valuation methodsDDM and ROE-g/COE-g terminal value

    Dividend discount model and terminal value based on ROE, growth rate, and cost of equity

    The target price is composed of FY25-28E dividends and a terminal value, with the terminal value calculated using the ROE-g/COE-g method. Key assumptions include a risk-free rate of 1.8%, an equity risk premium of 8.0%, beta of 1.15x, and a long-term growth rate of 4.5%, converted into a HKD target price using the spot CNY/HKD exchange rate.

  • merger_integrationphased integration roadmap

    Phased merger integration roadmap

    The first phase is to integrate institutional business within 3-6 months after the merger closes; the second phase is to advance the integration of retail brokerage and wealth management within about one year; the third phase is to integrate 15 subsidiaries within 2-3 years.

  • synergy_analysiswealth management and capital reallocation synergy

    Wealth management and capital reallocation synergy

    The report breaks potential synergies into higher wealth management product sales, cross-selling from investment banking to wealth management, margin financing expansion, capital injections into overseas subsidiaries, and shareholder resource opportunities.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • 3908.HK
    covered_company
    Strengths
    The merger timeline is clear, institutional business advantages are strong, and there is room for synergy-led expansion in wealth management and international business. JPMorgan maintains Overweight and names it a sector top pick.
    Weaknesses
    Retail brokerage integration involves licenses, client migration, branches, and front/middle/back-office processes, making execution more complex. Capital allocation and regulatory ratios still need to progress.
    Comparison
    Compared with Dongxing and Cinda, CICC is more fee-income driven, with fee-based business contributing more than 50% of revenue. It is more differentiated in mid- to high-end investment banking and international business, while Dongxing and Cinda have stronger retail foundations and regional networks and are relatively more capital-intensive.
    Risks
    A sharp market correction, policy or regulatory constraints, and excessively rapid growth in capital-intensive businesses could create potential equity financing and dilution risk.
  • Dongxing
    merger_counterparty_or_integration_asset
    Strengths
    Its retail business base and regional network can complement CICC's existing business and may absorb CICC's wealth management product sales and cross-selling capabilities.
    Weaknesses
    Current IB-to-wealth cross-sell contribution remains low, and integration must address licenses, client migration, and operating systems.
    Comparison
    It is more oriented toward proprietary or capital-intensive business than CICC; its margin financing and securities lending balance is about RMB20bn, significantly below CICC's roughly RMB70bn.
    Risks
    The pace of integration, staff stability, and the absorption of regional branches may affect synergy realization speed.
  • Cinda
    merger_counterparty_or_integration_asset
    Strengths
    Its retail base, regional network, and capital-intensive businesses can complement CICC.
    Weaknesses
    There is still room to improve wealth management product sales and cross-selling from investment banking clients.
    Comparison
    Its margin financing and securities lending balance is about RMB20bn, below CICC's roughly RMB70bn; its business is more geared toward secondary markets, whereas CICC has relatively more primary-market allocation.
    Risks
    License integration, regulatory ratios, and client migration may affect near-term synergy implementation.

Key data

  • Current priceHK$20.30Price for 3908.HK shown on the report cover.
  • Target priceHK$24.50Target price date is 2026-12-31.
  • Implied upsideabout 20.7%Calculated from the HK$24.50 target price and HK$20.30 current price.
  • Merger completion timingexpected in September 2026The merger target timing stated by management on the call.
  • Institutional business integration window3-6 months after mergerCovers investment banking, fixed income, equity proprietary trading, asset management, and research businesses.
  • Retail business integration windowabout one yearRetail brokerage involves licenses, client migration, branches, and operations, making it more complex.
  • Long-term subsidiary integration scope15 subsidiaries, within 2-3 yearsIncludes futures, public funds, international, private equity, and alternatives businesses.
  • Potential incremental wealth-management revenueRMB1.5-2.0bnAssumes Dongxing and Cinda wealth management product sales revenue contribution rises to CICC's current level.
  • IB-to-wealth cross-sell contribution10-15%CICC's current contribution from this type of cross-selling is 10-15% of wealth management revenue, while Dongxing and Cinda are currently lower.
  • Margin financing and securities lending capital sensitivityabout RMB140mn of additional margin financing and securities lending balance supported by every RMB100mn of net capitalCapital-to-margin-financing balance sensitivity disclosed by management.
  • CICC margin financing and securities lending balanceabout RMB70bnDongxing and Cinda each have about RMB20bn.
  • International business revenue growth+58%Management said international business revenue grew 58% last year.
  • International business ROEabove 20% in 1QManagement said all six business lines performed strongly.
  • International business leverageabove 7x by end-2025, 8.2x in 1Q26The increase was mainly driven by client-demand-led activity.

Impact & implications

The investment implication for 3908.HK is positive. The announcement and conference call turn the merger from a conceptual expectation into a trackable execution roadmap, reducing the valuation discount caused by delay risk and unclear synergies. If institutional integration, wealth management replication of CICC's experience, margin financing expansion, and international business capital support all progress, the market may raise its expectations for CICC's post-merger earnings power and ROE.

Risks

  • The market could experience a major correction and trigger government intervention, such as stabilization fund support or a suspension of IPO approvals.
  • Growth in capital-intensive businesses could be stronger, which may lead to potential equity financing and dilution risk.
  • Merger integration involves licenses, personnel, client migration, branches, and operating systems, and execution complexity may be higher than expected.
  • Capital deployment, regulatory ratios, and market conditions may limit the pace of expansion in margin financing, secondary markets, and overseas business.
  • Recovery in primary-market capital allocation may be slower than in secondary markets, affecting the pace at which high-return businesses are realized.

What to watch

  • Whether the merger is completed around September 2026 as management expects.
  • Whether institutional business integration is completed as planned within 3-6 months after the merger.
  • The integration plans, license handling, and client migration progress for retail brokerage and the three wealth management subsidiaries.
  • Whether the wealth management product sales revenue contribution ratio at Dongxing and Cinda can move closer to CICC's level.
  • Whether the 10-15% upside room from investment banking cross-selling into wealth management is realized.
  • Whether additional net capital is converted into margin financing and securities lending balance expansion.
  • Whether international business receives regulatory support and completes further capital injection.
  • Whether cost discipline continues, and whether cost-saving measures such as systems reuse and office-space integration show up in profit improvement.
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins